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Abstract: Hyaluronidase enzyme (HAase) has a role in the dissolution or disintegration of hyaluronic
acid (HA) and in maintaining the heathy state of skin. Bioassay-guided fractionation of Ravenala
madagascariensis (Sonn.) organ extracts (leaf, flower, stem, and root) testing for hyaluronidase inhibition
was performed followed by metabolic profiling using LC–HRMS. Additionally, a hyaluronidase
docking study was achieved using Molecular Operating Environment (MOE). Results showed that
the crude hydroalcoholic (70% EtOH) extract of the leaves as well as its n-butanol (n-BuOH) partition
showed higher HAase activity with 64.3% inhibition. Metabolic analysis of R. madagascariensis resulted
in the identification of 19 phenolic compounds ranging from different chemical classes (flavone
glycosides, flavonol glycosides, and flavanol aglycones). Bioassay-guided purification of the leaf
n-BuOH partition led to the isolation of seven compounds that were identified as narcissin, rutin,
epiafzelechin, epicatechin, isorhamnetin 7-O-glucoside, kaempferol, and isorhamnetin-7-O-rutinoside.
The docking study showed that narcissin, rutin, and quercetin 3-O-glucoside all interact with
HAase through hydrogen bonding with the Asp111, Gln271, and/or Glu113 residues. Our results
highlight Ravenala madagascariensis and its flavonoids as promising hyaluronidase inhibitors in natural
cosmetology preparations for skin care.
Molecules 2020, 25, 1714; doi:10.3390/molecules25071714 www.mdpi.com/journal/molecules
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1. Introduction
The skin is the external or exterior organ of our bodies which plays as a fence against chemical,
physical, and biological pollutants [1]. Skin aging is the combination of natural aging with photo aging,
where both include physical changes, atrophy of extracellular matrix in the dermal and epidermal
layers which causes visible signs on the skin’s surface [2,3]. The dermal parts of the skin are responsible
for keeping its firmness, flexibility, and moisture retention and are constantly being broke down by
enzymes like collagenase, elastase, and hyaluronidase, leading to wrinkle forming, furthermore, free
radicals and other oxidants speed this process. Thus, components that suppress the enzymes or play as
antioxidants reduce wrinkle forming [4]. Hyaluronidase enzyme is a mucopolysaccharide-hydrolyzing
enzyme that causes the degradation of hyaluronic acid (HA), an important small molecule, which fills
the space between collagen and elastin fibers, and helps maintain skin moisture levels [5–9]. It serves as
an integral part of the extracellular matrix and is responsible for improving hydration which improves
the appearance of fine lines and wrinkles [6,10–12]. Inhibition of hyaluronidase enzyme (HAase) is
potent at regulating agents, which are important for maintaining the balance between catabolism and
anabolism of HA. There are many chemical classes such as alkaloids, polyphenols, flavonoids, and
terpenoids that have shown HAase inhibition [13–16]. Earlier studies proved that the efficient HAase’s
inhibitory ability of some flavonoids, like apigenin, luteolin, quercetin, kaempferol, and rutin is due
to their closely related structure [17], on the other hand the activity towards Hyal increases with the
increasing the number of hydroxyl groups, especially in the 2,3′ position (quercetin) and 5′(myricetin)
and decreased after glycosylation or substitution of hydroxyl groups [13,14]. Also, natural extracts
such as brown seaweed (Padina pavonica) have shown an inhibitory effect on hyaluronidase and is
used as an anti-aging product [18]. The methanolic extracts of Malaxis acuminate leaves and stems
exhibited photo protective activity against UV-A and UV-B radiation in addition to acting as HAase
inhibitors. GC–MS of both leaf and stem extracts showed the presence of phenolic acids, sterols,
α-hydroxy acids, amino acids, sugars, and glycosides which coincides with the use of M. acuminata as
a rejuvenating remedy in several Ayurvedic formulations [19]. The n-butanol, aqueous and methanol
extracts of Pleurotus citrinopileatus were also found to act as hyaluronidase inhibitors by 9.7%, 10.8%,
and 25.4%, at concentrations of 2.0, 1.1, and 4.1 mg/mL, respectively, the aqueous and methanolic
extract of Pleurotus tuber-regium showed hyaluronidase inhibition by 22.19% and 3.94%, respectively,
at 100 µg/mL while Trametes lactinea aqueous and acetonic extract inhibited hyaluronidase by 88.6%
and 88.3%, respectively [6]. The number of free phenolic and ortho-dihydroxyphenolic groups in
molecules increased their effects in both DPPH and HAase assays [20]. Positive correlations between
hyaluronidase inhibitory activity, total phenolic content, and total flavonoids were linked to the
presence of polyphenolics and flavonoids [14,21].
On the other hand, abundant varieties of phytochemicals such as epicatechin, ziyuglycoside I,
asiaticoside, aloin, ginsenoside, gallic acid, hydroxychavicol, hydroxybenzoic acid, hydroxycinnamic
acid, magnolol, and curcumin act as free radical scavengers which prevent transdermal loss of water to
keep skin free from wrinkles, ultimately leading to younger and healthier skin [22,23].
Ravenala madagascariensis, commonly called traveler’s tree or traveler’s palm, belongs to the family
Strelitziaceae [24]. It is indigenous to Madagascar and is easily cultivated in the tropical regions, in
particular as an ornamental tree [25]. The major classes of the chemical constituents identified so far in
R. madagascariensis are flavonoids, tannins, saponins, terpenoids, and steroids [26]. Its hydro-alcoholic
extract is used as a hydrating agent in cosmetic products, to achieve proper skin hydration [27]. In this
study, varying plant organ extracts (leaf, flower, stem, and root) of R. madagascariensis were investigated
for their HAase inhibitory activity. Subsequently, bioassay-guided fractionation and isolation of the
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major bioactive compounds was carried out leading to the rediscovery of multiple known compounds.
Moreover, the interaction of isolated compounds to the HAase via docking studies was carried out.
2. Results
The crude extracts of different organs (leaf, flower, stem, and root) were subjected to hyaluronidase
inhibition activity (Table 1), where the crude extract of the leaves was the most active HAase inhibitor
(78.9%). These findings of the crude extracts of leaves and stems were much better that previously
reported when compared with the aqueous and methanolic extract of Pleurotus tuber-regium that showed
inhibiton by 22.19% and 3.94%, respectively at 100 µg/mL while it showed comparable activities with
those of Trametes lactinea aqueous and acetonic extract that inhibited hyaluronidase by 88.6% and 88.3%,
respectively [6]. Additionally, partitions of the leaves were evaluated for their HAase inhibition activity,
where hydro-alcoholic as well as its n-BuOH extracts of R. madagascariensis showed higher inhibition
(90% and 64.3%, respectively). The n-BuOH was subjected to chromatographic purification, yielding
seven compounds identified as narcissin, rutin, epicatechin, isorhamnetin 7-O-glucoside, isorhamnetin
7-O-rutinoside, epiafzelechin, and kaempferol. The isolated compounds were tested for their inhibition
percentage (Table 1). Results showed that epiafzelechin and epicatechin the highest inhibition value
with 36.5% and 34.4%, respectively. While the other isolated ones are less, these results were going with
previously reported that increasing the number of hydroxyl groups, especially in 2,3′ and 5′(myricetin)
and decreased after glycosylation or substitution of hydroxyl groups. [13,14]. The Docking studies
were carried out to describe the interaction properties between the isolated ones and the enzyme,
showed that narcissin, rutin, and Quercetin 3-O-glucoside interact with HAase through the formation
of hydrogen bonds with the Asp111, Gln271, and/or Glu113 residues.
2.1. Metabolic Profiling
Chemical profiling of the secondary metabolites present in R. madagascariensis leaves was carried
out using LC-HRESIMS for dereplication purposes. The results showed a diversity of constituents
ranging from different chemical classes, where flavonoids predominated. The identified compounds
(Figure 1) were tentatively identified by multiple databases (LipidMaps, METLIN and DNP databases).
From these, the peak with m/z 624.391, with a molecular formula C28H32O16, was dereplicated as
the flavonoid, glycoside isorhamnetin-3-O-rutinoside (narcissin) (1), which was previously isolated
from R. madagascariensis [28], while the peak with m/z 611.163, with a molecular formula C27H30O16,
was identified as quercetin-3-O-rutinoside (rutin) (2), previously isolated from R. madagascariensis [28].
The peak with m/z 816.209, with a proposed molecular formula C38H40O20, was specified as
kaempferol-3-O-glycoside (3), already informed from close species of Zingiberales [29]. The peak at m/z
832.206, with an expected molecular formula C38H40O21, was dereplicated as quercetin-3-O-glucoside
(4), which was previously identified from R. madagascariensis [28]. The peak at m/z 1090.314, with
the suggested molecular formula C50H58O27, was dereplicated as kaempferol-3,7-diglycoside (5).
The peak at m/z 302.101, with a suggested as molecular formula C20H14O3, was dereplicated as
8-hydroxy-7-methoxy-6-phenylphenalen-1-one (6) which was previously isolated from genus of
Strelitzia, family Strelitziaceae [30]. Similarly, a flavone glycoside with the molecular formula C35H44O22,
was distinguished as 3,4′,5,7-Tetrahydroxy-3′,5′-dimethoxyflavone-3-O-α-l-rhamnopyranoside (7)
from the peak at m/z 816.232 [31]. The experimental results revealed that kaempferol, quercetin, rutin,
apiin, and isorhamnetin interact with hyaluronidase, induce conformational changes and therefore
inhibit hyaluronidase catalytic activity (M. Liu et al., 2013). Additionally, related compounds identified
for the first time from this species were also characterized as apiin (8), shiraiachrome A (9), loliolide
(10), hydroxyanigorufone (11), lachnanthocarpone (12), confertoside (13), dendroside D (14) from the
family, based on their m/z 564.157, 546.161, 196.118, 288.087, 288.087, 608.273, 592.278, respectively and
in accordance with the molecular formulas C26H28O14, C30H26O10, C11H16O3, C19H12O3, C19H12O3,
C27H44O15, C27H44O14, respectively.
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Figure 1. Structures of the dereplicated metabolites from Ravenala madagascariensis.
2.2. Identification of Purified Compounds
The isolated compounds (Figure 2) were structurally elucidated established on their physiochemical,
chromatographic properties, and spectroscopic analysis (UV, ESI-MS, 1H-NMR and 13C-NMR), as well
as comparison to standards. The isolated compound 1 was obtained as yellow amorphous powder,
dark purple color under UV light which changed to bright yellow with ammonia vapor. Rf = 0.38 by
using CH2Cl2/ MeOH (8:2) as solvent system for TLC. 1H-NMR: (400 MHz, MeOD), δ 7.84 (1H, s, H-2′),
δ 7.52 (1H, d, J = 8.0 Hz, H-6′), δ 6.95 (1H, d, J = 8.0 Hz, H-5′), δ 6.4 (1H, s, H-8), δ 6.2 (1H, s, H-6),
δ 5.2 (1H, d, J = 7.5 Hz, H-1′′), δ 4.5 (1H, bs, H-1′”), δ 3.83 (3H, s, OMe-3′), δ3.04–3.85 (8H, m, H-2′′,
H-3′′, H-4′′, H-5′′, H-2′”, H-3′”, H-4′”, H-5′”), δ 1.1(3H, d, J = 6 Hz, CH-6′”). 13C-NMR: (100 MHz,
MeOD), 177.9, 164.6, 157.5, 157.1, 149.4, 146.9, 134.0, 122.6, 121.6, 114.7, 113.1, 104.3, 103.0, 102.0, 98.6,
93.5, 76.7, 75.9, 74.5, 72.4, 70.9, 70.7, 70.2, 68.4, 67.1, 55.6, 16.6. From previous data it was identified as
narcissin [28,32].
Compound 2 was the same as 1 except the absence of OCH3 signals at δ 3.83 and 55.6 and was
identified as rutin [31], compound 15 was obtained as yellow amorphous powder, dark purple color
under UV light which changed to bright yellow with ammonia vapor. Rf = 0.18 by using CHCl3/
MeOH (9.5:0.5) as solvent system for TLC. 1H-NMR: (400 MHz, MeOD), δ 7.93 (1H, s, H-2′), δ 7.79 (1H,
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d, J = 8.0 Hz, H-6′), δ 6.94 (1H, d, J = 8.0 Hz, H-5′), δ 6.83 (1H, s, H-8), δ 6.49 (1H, s, H-6), δ 5.05 (1H, d,
J = 7.2 Hz, H-1′′), δ 3.96 (3H, s, OMe-3′), δ 3.04–3.85 (5H, m, H-2′′, H-3′′, H-4′′, H-5′′, H-6′′). 13C-NMR:
(100 MHz, MeOD), 177.9, 163.3, 161.2, 158.1, 156.6, 149.5, 147.3, 131.6, 122.6, 120.7, 114.8, 113.2, 106.0,
100.3, 101.1, 98.8, 92.6, 77.0, 76.5, 73.3, 69.7, 62.6, 55.1, as isorhamnetin-7-O-glucoside which [33,34],
while compound 16 was obtained as yellow amorphous powder, dark purple color under UV light
which changed to bright yellow with ammonia vapor. Rf = 0.14 by using CHCl3/ MeOH (9.8:0.2) as
solvent system for TLC. 1H-NMR: (400 MHz, MeOD), δ 8.09 (1H, d, J = 8.0 Hz, H-2′, H-6′), δ 6.94 (1H,
d, J = 8.0 Hz, H-3′,H-5′), δ 6.43 (1H, s, H-8), δ 6.21(1H, s, H-6), 13C-NMR: (100 MHz, MeOD), 177.9,
165.4, 161.5, 158.2, 157.4, 131.3, 129.3, 122.3, 115.0, 104.5, 98.9, 93.3 as kaempferol [35,36].
Figure 2. The isolated compounds structures from Ravenala madagascariensis.
Compound 17 was obtained as yellow amorphous powder, dark purple color under UV light
which changed to bright yellow with ammonia vapor. Rf = 0.16 using CH2Cl2/ MeOH (7.5:2.5) as
solvent system for TLC. 1H-NMR: (400 MHz, MeOD), δ 7.96 (1H, s, H-2′), δ 7.67 (1H, d, J = 8.0 Hz,
H-6′), δ 6.95 (1H, d, J = 8.0 Hz, H-5′), δ 6.8 (1H, s, H-8), δ 6.51 (1H, s, H-6), δ 5.2 (1H, d, J = 7.5 Hz,
H-1′′), δ 5.09 (1H, bs, H-1′”), δ 3.83 (3H, s, OMe-3′), δ 3.04–3.85 (8H, m, H-2′′, H-3′′, H-4′′, H-5′′,
H-2′”, H-3′”, H-4′”, H-5′”), δ 1.1 (3H, d, J = 6 Hz, CH-6′”). 13C-NMR: (100 MHz, MeOD), 177.9, 163.3,
161.2, 158.1, 156.6, 149.6, 146.9, 134.19, 122.9, 121.4, 114.7, 113.2, 105.8, 102.6, 101.1, 99.6, 94.6, 76.7, 75.9,
74.5, 72.4, 70.9, 70.7, 70.2, 68.4, 67.3, 55.4, 16.5 as isorhamnetin-7-O-rutinoside [34], on the other hand
compound 18, was obtained as a colorless needle crystals, dark purple color under UV light gave red
with Vanillin/ H2SO4, Rf = 0.5 by using CH2Cl2/ MeOH (8.5:1.5) as solvent system for TLC. 1H-NMR:
(400 MHz, MeOD), δ 7.3 (1H, d, J = 8.5 Hz, H-2′, H-6′), δ 6.8 (1H, d, J = 8.6 Hz, H-5′, H-3′), δ 5.99 (1H,
d, J = 2.2 Hz, H-8),δ 5.94 (1H, d, J = 1.5 Hz, H-6), δ 4.8 (1H, s, H-2), δ 4.2 (1H, m, H-3), δ2.9, 2.88 (1H, dd,
J = 16.8, 4.5 Hz, H-4a, H-4b). 13C-NMR: (100 MHz, MeOD), 27.9, 66.1, 78.5, 94.6, 95.1, 98.8, 114.4, 127.8,
127.9, 130.2, 156.0, 156.2, 156.4, as epiafzelechin [37], and compound 19 was the same with only one
missing aromatic proton at position 3‘ at δ 6.8 and was identified as epicatechin [38,39].
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2.3. Modeling Study Exhibiting the Binding Ability of Polyphenolic Compounds to HAase
To predict the precise binding sites on HAase and explore the interaction between the target
compounds and HAase systematically, a docking study was run using Molecular Operating
Environment (MOE; Chemical Computing Group Inc., Montreal, Canada). From the docking calculation,
the smallest energy-ranked results of the target compounds -HAase conformations are outlined in
Table 2. By comparing, of the data from Table 1 with the data from Table 2, the noticed free energy
change (∆G◦) for the target compounds -HAase systems was consistent with the results of biological
studies. As shown in Figure 3, all the compounds containing the flavonoid nucleus were situated in
the hydrophobic cavity of HAase and were encircled by hydrophilic and hydrophobic amino acids.
Therefore, mainly the interaction between flavonoids and HAase is due to electrostatic forces and
hydrophobic interactions. However, due to more hydrophobic amino acids lining quercetin in the
binding site, hydrophilic interaction was more conspicuous than electrostatic force in the quercetin
-HAase system. As shown in Figure 3, many amino acid residues, such as Ser303, Gln271, Glu113,
Tyr227, Asp111, Tyr55 and Ser304, manifested in the binding of each compound with HAase [40].
These results indicate that these residues would perform a significant role in the interaction between
the illustrated compounds and HAase and might constitute the catalytic site of HAase. Furthermore,
due to the presence of different ionic and polar groups, there are also large numbers of hydrogen bonds
in HAase binding site. As shown in the following figures, one of the hydrogen bonds is formed with the
Asp111, Gln271 and/or Glu113 residues in the flavonoid (narcissin, rutin and quercetin-3-O-glucoside)
-HAase systems (Figure 3). The compounds that exhibited the lowest binding free energy values were
rutin and narcissin with values –7.119 Kcal/mol and –6.853 Kcal/mol, respectively, which agrees with
their inhibitory effect on HAase. Therefore, according to docking studies and the biological screening,
it could be suggested that flavonoid or flavonoid-like compounds have the ability bind to the HAase
catalytic site, which would suppress the activity of the enzyme.
Table 1. Hyaluronidase inhibition of Ravenala madagascariensis ethanolic extracts and pure compounds
isolated in this study.





Leaves 78.9% ± 0.023 n-Hexane 28.6% ± 0.065 Narcissin 27.2% ± 0.043
Stem 56.1% ± 1.082 DCM 3.8% ± 1.044 Rutin 23.7% ± 01.070
Flower 9.4% ± 0.1012 EtOAc 32% ± 0.1334 Epicatechin 34.4% ± 0.038
Root 20.5% ± 0.006 n-BuOH 64.3% ± 0.015 Epiafzelechin 36.5% ± 0.045
Tannic acid 95.4% ± 0.006 total 70% EtOH 90 % ± 0.006 Isorhamnetin 7-O-glucoside 11.4% ± 0.022Kaempferol 8.7% ± 0.039
Table 2. The lowest energy ranked results of target compounds HAase binding configurations.










Dendroside D −6.701 2
Loliolide −4.021 8
Shiraiachrome A −6.08 9
The displayed score is the mean of 3 sequential runs. The docking technique was validated by successful
pose-retrieval docking trial of the ligand (score: −5.370).
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Figure 3. Docked poses relative or proportional to the minimum energy configuration for narcissin,
rutin & quercetin binding to HAase. (Panel a) Binding pattern of narcissin colored by element, ball and
stick into HAase showing 4 hydrogen bond interactions (dotted lines). (Panel b–d) displayed the most
active flavonoids narcissin (b), rutin (c) and quercetin (d).
Structure activity relationship showed that: The C2,3 double bonded flavonoids have high
potency [13,14], the flavonoid glycosides were more potent in their inhibitory effects than aglycone
and the ortho-dihydroxyl substitution exhibited greater inhibition than those singly hydroxylated,
while the methoxy substitution decreased the inhibitory effects. The following flavonoid structure
conferred potent inhibitory effect: the C2,3 double bond and ortho-dihydroxyl substitution.
3. Materials and Methods
3.1. Plant Material
Ravenala madagascariensis (Sonn.) leaves, flowers, stem and root were collected from the El Orman
garden, Egypt, in August 2015. The plant was authenticated by Professor Ibrahim Ahmed El-Garf
(Department of Botany and Microbiology, Faculty of Science, Cairo University, Giza, Egypt). The leaves
were air-dried, powdered, and kept in amber-colored, air-tight glass containers at low temperature for
preservation of chemical materials for future testing.
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3.2. Chemicals and Reagents
Brain heart infusion media, agar, sodium hyaluronidate, human albumin, sheep blood agar,
incubator, Staphylococcus aureus, glacial acetic acid, Tryptic soya broth (TSB), incubator, autoclave,
filters (pore size, 0.22 µm), 70% ethanol (EtOH), distilled H2O, Hyaluronic acid, 5% DMSO, methanol,
sodium tetraborate, standard inhibitor (Tannic acid and p-dimethyl amino benzaldehyde (PDMAB).
All chemical substances and standards were provided from Sigma-Aldrich (St Louis, MO, USA).
3.3. Extraction and Isolation
Dried plant material was detached into leaves, flowers, stem and root and then ground.
Subsequently, each part was extracted with 70% ethanol (EtOH) by cold maceration, and then
concentrated under vacuum. The powdered leaves (1.7 kg) were extracted exhaustively at room
temperature then concentrated to yield 400 g. Approximately half of this extract (~200 g) was
resuspended in distilled H2O and successively fractionated with solvents of increasing polarity:
n-hexanes, dichloromethane (DCM), ethyl acetate (EtOAc) and finally n-BuOH.
The n-BuOH extract (25 g) was undergone to a polyamide column (100 × 5 cm, 250 g) with an
increasing elution gradient of MeOH: H2O in increments of 10% more H2O. Fractions (100 mL each)
were collected, evaporated under reduced pressure and screened by TLC using various solvent systems.
Similar fractions were pooled together yielding 12 fractions. The fourth fraction was subjected to
a silica gel column (60 × 3 cm, 100 g) with a gradient eluting from DCM: MeOH yielding a further
21 subfractions. Compounds 1 (10 mg), 2 (10 mg) and 3 (20 mg) were isolated from the sixth, eighth
and tenth subfractions, respectively, by further separation using a sephadex LH-20 column (38 × 3 cm,
40 g) with an isocratic elution of MeOH: H2O (80:20) The ninth fraction was submitted to a silica gel
column (60 × 3 cm, 100 g) with a gradient eluting from DCM: MeOH followed by a sephadex LH-20
column (38 × 3 cm, 40 g) eluted with 80% MeOH to give (4, 20 mg) and (5, 25 mg). Finally, the tenth
fraction was separated by a sephadex LH-20 column (38 × 3 cm, 40 g) with a 80% MeOH isocratic
elution subsequently followed by another sephadex LH-20 column (38 × 3 cm, 40 g) isocratic elution
with saturated n-butanol to give (6, 15 mg) and (7, 25 mg).
3.4. Biological Activity Study
3.4.1. Preparation of Hyaluronidase
Following the procedure laid out by Smith et al., 1968 [41], 100 mL of brain heart infusion
media was prepared with 1 g of agar, autoclaved for 15 min at 121 ◦C, and cooled to 46 ◦C; then,
a 2 mg/mL solution of sodium hyaluronidate, was added to the cooled medium to a final concentration
of 400 µg/mL. 5% human albumin was added under constant mixing to give a final concentration of 1%.
Plates were then poured to a depth of 3–4 mm and left to solidify at 4 ◦C. The isolates of Staphylococcus
aureus were grown on sheep blood agar until growth was clearly observed. A single colony was
streaked onto the hyaluronic acid medium, incubated at 37 ◦C, and observed daily until growth was
detected (24 to 72 h). On the day growth was first observed, the plate was immersed with 2N glacial
acetic acid which binds hyaluronic acid and albumin, forming a white precipitate. Hyaluronidase
production was confirmed if a clear zone was observed.
3.4.2. Hyaluronidase Inhibition Assay
The strains of Staphylococcus aureus were expanded overnight in TSB at 37 ◦C with shaking, then
sub-cultured 1:1000 and grown at 37 ◦C for the time specified below. Spent culture medium was
isolated with Spin-X filters (pore size, 0.22 µm) then frozen at −20 ◦C until used in biological assays.
50 µL of spent culture medium was incubated for 15 min at 37 ◦C with 50 µL of the used test inhibitor
(1 mg/mL dissolved in 5% DMSO). Hyaluronic acid (HA) (100 µL at 1 mg/mL) was blended and
permitted to react at 37 ◦C for 15 min. To stop the reaction 25 µL of sodium tetraborate solution (0.8 M,
pH 9.1) was added and then the reaction mixture was vortexed and boiled for 3 min. The positive
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control (tannic acid, was used as HAase inhibitor) [42–44] and negative control were made using the
identical procedure but without the test or standard inhibitor (50 µL of 5% DMSO). In parallel, 50 µL
of 5% DMSO and 50 µL spent medium were added to 125 µL of stop solution (1 mg/mL hyaluronic
acid, 0.8 M potassium tetraborate, pH 9.1) at time zero, vortexed, and boiled for 3 min. The samples
were distributed into a 96-well microtiter plate in quadruplicate. Freshly prepared PDMAB solution
(10% [w/v] p-dimethyl amino benzaldehyde, 12.5% [v/v] 10M HCl, and 87.5% [v/v] glacial acetic acid)
was added to each well. The plate was incubated at 37 ◦C for 20 min to let the color change. The
absorbance at 590 nm was evaluated by using a microplate reader
% inhibition = (Ao − A1)/Ao × 100 (1)
where A1 is the absorbance of the standard/ extracts, Ao is the absorbance of the control.
3.5. Metabolic Profiling
The crude extracts of R. madagascariensis (leaves, flowers, stem, and root) were undergone to
metabolomic using LC-HRESIMS analytical methods as stated by Abdel Mohsen et al. [45]. Each extract
(1 mg/mL dissolved in MeOH) was analyzed separately on an Accela HPLC with an Accela UV-Vis
coupled to an Exactive (Orbitrap) MS spectrometer from Thermo Fisher Scientific (Berman, Germany).
Purified water (a) and acetonitrile (b) used as mobile phase with 0.1% formic acid in both. The gradient
began at 10% (b) to 100% (b) in 30 min and kept isocratic elution for the next 5 min before back to 10%
for 1 min (flow rate of 300 µL/ min). Then mobile phase was re-equilibrated for 9 min previous to the
following injection. By using untargeted Higher-energy Collision Dissociation (HCD) mechanism,
the range of mass was set from m/z 50–1000 for MS/MS and m/z 100–2000 for ESI-MS using in source
collision-induced dissociation (CID). The raw data was derived in MZmine 2.12, a framework for
differential analysis of MS data. The individual peaks were detected by chromatogram deconvolution.
The retention time normalizer was applied for chromatographic alignment and gap-filling. An Excel
macro was applied on the positive ionization mode data files produced by MZmine to extract the peaks
from each samples and dereplicated each ion peak with compounds in the customized database (using
RT and m/z threshold of ±5 ppm), which supplied details on the assumed identities of metabolites in all
extracts. By comparison with LipidMaps, DNP and METLIN databases, 19 metabolites were identified.
3.6. Molecular Docking Investigation
Docking calculations were achieved using (MOE) Molecular Operating Environment on a HAase
model (PDB code 1FCV, http://www.rcsb.org/pdb/home/home.do). The structures of the compounds
were generated by Chemdraw Ultra 8.0. Docking emulation was achieved on the identified compounds
with the next protocol: (1) Enzyme structures were examined for missing atoms, bonds and contacts,
as well as (2) hydrogen atoms were joined to the enzyme structure. (3) Then by using the builder
module, the ligand molecules were established and were energy minimized. (4) The active site was
created using the MOE Alpha Site Finder. (5) Ligands were docked within the HAase active site
using MOE Dock with simulated annealing utilized as the search protocol and CHARMm molecular
mechanics force field. (6) The smallest energy conformation of the docked ligand complex was chosen
and undergone to more energy minimization using CHARMm force field. Determination of precision
of this docking protocol was carried out by redocking the co-crystallized ligand into the HAase vital
site. This method was rerun triple times and the best ranked solutions of the ligand displayed RMSD
values of 1.84 A◦ from the site of the co-crystallized ligand for HAase. Generally, RMSD values smaller
than 2.0 A◦ show that the docking protocol is efficient to accurately promising the binding orientation
of the co-crystallized ligand [46]. This protocol was deemed to be convenient for the docking of the
test compounds into the active site model of HAase.
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4. Conclusions
This work showed the importance of natural products specially phenols and polyphenols as a
competitive inhibitor of hyaluronidase as a key enzyme in healthiness of skin. These findings may assist
for the application of plant under investigation in future in cosmetic and in phototherapy as a dietary
supplement with fewer side effects. On the other hand, it gave insight about the proposed interactive
sites between compounds and the enzyme that may help in optimization of these compounds for
production of more active compounds.
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